Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619242 · ClinicalTrials.gov registry record · NA
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT00619242 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 3 participants.
The verdict
NCT00619242, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To determine whether sorafenib is able to change pre-cancerous cells in a way that we believe is important in the progression of cancer.
Interventions
- DRUG sorafenib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2006-06 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619242
The ClinicalTrials.gov registry entry for NCT00619242 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sorafenib is the first listed.
NCT00619242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00619242 about?
NCT00619242 is a clinical study titled "The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer". To determine whether sorafenib is able to change pre-cancerous cells in a way that we believe is important in the progression of cancer.
What is the current status of trial NCT00619242?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2006-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00619242?
The interventions under investigation include: sorafenib (DRUG).
Who is sponsoring clinical trial NCT00619242?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.